Harmonization of Commercial ELISA Methods for the Measurement of Prothrombin Fragment 1.2: Is It Feasible?

Thromb Haemost 1995; 73(03): 548
DOI: 10.1055/s-0038-1653813

Letters to the Editor

Schattauer GmbH Stuttgart

Armando D’Angelo

Coagulation Service and Epidemiology Unit, Istituto Scientifico H. S. Raffele, Milano, Italy

,

Patrizia Della Valle

Coagulation Service and Epidemiology Unit, Istituto Scientifico H. S. Raffele, Milano, Italy

,

Giliola Calori

Coagulation Service and Epidemiology Unit, Istituto Scientifico H. S. Raffele, Milano, Italy

,

Laura Galli

Coagulation Service and Epidemiology Unit, Istituto Scientifico H. S. Raffele, Milano, Italy

,

Silvana Vigano D’Angelo

Coagulation Service and Epidemiology Unit, Istituto Scientifico H. S. Raffele, Milano, Italy

References
1 Tripodi A, Chantarangkul V, Bottasso B, Mannucci PM. Poor comparability of prothrombin fragment 1+2 values measured by two commercial ELISA methods: influence of different anticoagulants and standards. Thromb Haemost 1994; 71: 605-608
2 Bauer KA, Rosenberg RD. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation. Blood 1987; 70: 343-350
3 Bauer KA, Barzegar S, Rosenberg RD. Influence of anticoagulants used for blood collection on plasma prothrombin fragment F1+2 measurements. Thromb Res 1991; 63: 617-628
4 Armitage P, Barry G. Statistical methods in medical research. 2. edition Oxford: Blackwell Scientific Publications; 1987
5 Fleiss JL. Statistical methods for mates and proportion. New York, NY: Wiley Interscience; 1981. pp 223-225
6 Cicchetti DV. Assessing inter-rater reliability for rating scales: Resolving some basic issues. Br J Psychiatry 1976; 129: 452-456